|
| 34774650 | Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond. | Radiother Oncol | 2022 |
| 35038433 | Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial. | Lancet Oncol | 2022 |
| 34862242 | Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body Radiotherapy. | Clin Cancer Res | 2022 |
| 34400269 | Long-Term Outcomes of NRG Oncology/RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer. | Int J Radiat Oncol Biol Phys | 2022 |
| 34836735 | Four-year Prostate-specific Antigen Response Rate as a Predictive Measure in Intermediate-risk Prostate Cancer Treated With Ablative Therapies: The SPRAT Analysis. | Clin Oncol (R Coll Radiol) | 2022 |
| 33035622 | Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control. | Radiother Oncol | 2021 |
| 33493615 | Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients. | Int J Radiat Oncol Biol Phys | 2021 |
| 33855816 | Dosimetric and clinical outcomes of SpaceOAR in men undergoing external beam radiation therapy for localized prostate cancer: A systematic review. | J Med Imaging Radiat Oncol | 2021 |
| 34585025 | Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series. | Adv Radiat Oncol | 2021 |
| 32663537 | Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients. | Radiother Oncol | 2020 |
| 31985516 | Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial. | Am J Clin Oncol | 2020 |
| 33391899 | Prostate Stereotactic Body Radiation Therapy With Halcyon 2.0: Treatment Plans Comparison Based on RTOG 0938 Protocol. | Cureus | 2020 |
| 30873385 | Hypofractionated Stereotactic Radiotherapy for Non-breast or Prostate Cancer Oligometastases: A Tail of Survival Beyond 10 Years. | Front Oncol | 2019 |
| 31762753 | Hypofractionated Stereotactic Radiation Therapy for Metastatic Adenocarcinoma ex Goblet Cell Carcinoid of the Appendix: Case Report and Literature Review. | Case Rep Oncol | 2019 |
| 31179045 | Stereotactic body radiation therapy versus metastasectomy for oligometastases. | J Thorac Dis | 2019 |
| 30773186 | Oligometastatic breast cancer treated with hypofractionated stereotactic radiotherapy: Some patients survive longer than a decade. | Radiother Oncol | 2019 |
| 30735235 | Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer. | JAMA Netw Open | 2019 |
| 31032106 | Short course radiation therapy for rectal cancer in the elderly: can radical surgery be avoided? | J Gastrointest Oncol | 2019 |
| 30825666 | NRG Oncology/RTOG 0438: A Phase 1 Trial of Highly Conformal Radiation Therapy for Liver Metastases. | Pract Radiat Oncol | 2019 |
| 26270442 | Stereotactic Body Radiotherapy for Lung Metastases from Colorectal Cancer: Prognostic Factors for Disease Control and Survival. | Am J Clin Oncol | 2018 |
| 28494653 | Patterns and Yearly Time Trends in the Use of Radiation Therapy During the Last 30 Days of Life Among Patients With Metastatic Rectal Cancer in the United States From 2004 to 2012. | Am J Hosp Palliat Care | 2018 |
| 29664795 | Impact of Right-sided Primary Tumor Location Among Patients With Oligometastatic Colorectal Cancer Treated With Stereotactic Body Radiotherapy. | Am J Clin Oncol | 2018 |
| 28710606 | SBRT for Hepatocellular Carcinoma: 8-Year Experience from a Regional Transplant Center. | J Gastrointest Cancer | 2018 |
| 28821268 | Hypo-fractionated SBRT for localized prostate cancer: a German bi-center single treatment group feasibility trial. | Radiat Oncol | 2017 |
| 29152425 | Stereotactic Body Radiotherapy for Low-Risk Prostate Cancer: A Ten-Year Analysis. | Cureus | 2017 |
| 27458572 | Predicting Biochemical Disease-Free Survival after Prostate Stereotactic Body Radiotherapy: Risk-Stratification and Patterns of Failure. | Front Oncol | 2016 |
| 27867636 | Oligometastases to the liver: predicting outcomes based upon radiation sensitivity. | J Thorac Dis | 2016 |
| 25222074 | Can Surgery be Avoided After Preoperative Chemoradiation for Rectal Cancer in the Era of Organ Preservation? Current Review of Literature. | Am J Clin Oncol | 2015 |
| 28799575 | Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma. | Adv Radiat Oncol | 2015 |
| 26557080 | Long-Term Survival of a Patient with Metastatic Small-Cell Carcinoma of the Stomach Treated with Radiation Therapy. | Case Rep Oncol | 2015 |
| 24382205 | Stereotactic body radiotherapy with or without external beam radiation as treatment for organ confined high-risk prostate carcinoma: a six year study. | Radiat Oncol | 2014 |
| 25229051 | Stereotactic body radiotherapy as treatment for organ confined low- and intermediate-risk prostate carcinoma, a 7-year study. | Front Oncol | 2014 |
| 25389521 | Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study. | Front Oncol | 2014 |
| 24581472 | Supraumbilical rash caused by nontarget radioembolization to the falciform artery. | J Vasc Interv Radiol | 2014 |
| 24575010 | Stereotactic body radiation therapy as a bridge to transplantation and for recurrent disease in the transplanted liver of a patient with hepatocellular carcinoma. | Case Rep Oncol | 2014 |
| 22278932 | Cyberknife radiosurgery in treating trigeminal neuralgia. | J Neurointerv Surg | 2013 |
| 24119836 | Health-related quality of life after stereotactic body radiation therapy for localized prostate cancer: results from a multi-institutional consortium of prospective trials. | Int J Radiat Oncol Biol Phys | 2013 |
| 24060175 | Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials. | Radiother Oncol | 2013 |
| 23668632 | Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years. | Radiat Oncol | 2013 |
| 23745991 | Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. | Radiat Res | 2013 |
| 23458468 | Multicentre results of stereotactic body radiotherapy for secondary liver tumours. | HPB (Oxford) | 2013 |
| 23233707 | Unresectable locally advanced pancreatic cancer: treatment with neoadjuvant leucovorin, fluorouracil, irinotecan, and oxaliplatin and assessment of surgical resectability. | J Clin Oncol | 2013 |
| 21533812 | Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research. | Support Care Cancer | 2012 |
| 23164305 | Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer. | Radiat Oncol | 2012 |
| 23275779 | Esophageal metastasis to the iris effectively palliated using stereotactic body radiation therapy and adjuvant intravitreal chemotherapy: case report and literature review. | Case Rep Oncol | 2012 |
| 22263926 | Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors. | Acta Oncol | 2012 |
| 22172906 | Stereotactic hypofractionated radiation therapy as a bridge to transplantation for hepatocellular carcinoma: clinical outcome and pathologic correlation. | Int J Radiat Oncol Biol Phys | 2012 |
| 22172903 | Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study. | Int J Radiat Oncol Biol Phys | 2012 |
| 20400244 | Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting. | Int J Radiat Oncol Biol Phys | 2011 |
| 22655249 | Stereotactic Body Radiation Therapy for Low- and Low-Intermediate-Risk Prostate Cancer: Is there a Dose Effect? | Front Oncol | 2011 |